• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT Back to Search Results
Model Number HERO 1001
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Arrhythmia (1721); Palpitations (2467)
Event Date 11/30/2014
Event Type  Injury  
Manufacturer Narrative
According to the report, "only heard information that there had been 3 revisions on patients who previously received a hero graft." additional information was received which indicated the hospital had "performed five hero graft implantations in five patients.We have performed five revisions in four patients." this report represents the third of four patients.According to the surgeons, "the third patient on which we performed revision after hero graft implantation was a (b)(6) woman.She received the hero graft on (b)(6) 2014, the revision was performed on (b)(6) 2014.The indication for the revision was heart arrhythmia and palpitations that were perceived as very disturbing by the patient.At the revision, the venous outflow component of the hero graft was shortened.We thought that the intravascular end of the hero graft lay too deep in the right atrium, thus causing the arrhythmia.After the shortening of the catheter the complaints of the patient were gone." the manufacturing records for lot h14vc041 were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.A review was performed of the available information.At this time, the role of the hero graft in these revisions cannot be determined with the available information, although graft revision/replacement is an established treatment for arteriovenous (av) graft complications.Cardiac arrhythmia is listed in the hero ifu as a potential intraoperative and post-operative complication.In this case of arrhythmia and palpitations, the symptoms appeared three days post-implantation.The surgeon stated that the "intravascular end of the hero graft lay too deep in the right atrium." directions on how to place the device are provided in the ifu.Without operative notes or further details about the device position it is not clear how this event occurred and if there were any surgical deviations from the specified methodology.Medical history is also unknown at this time.
 
Event Description
According to the report, "only heard information that there had been 3 revisions on patients who previously received a hero graft." additional information was received which indicated the hospital had "performed five hero graft implantations in five patients.We have performed five revisions in four patients." this report represents the third of four patients.According to the surgeons, "the third patient on which we performed revision after hero graft implantation was a (b)(6) woman.She received the hero graft on (b)(6) 2014, the revision was performed on (b)(6) 2014.The indication for the revision was heart arrhythmia and palpitations that were perceived as very disturbing by the patient.At the revision, the venous outflow component of the hero graft was shortened.We thought that the intravascular end of the hero graft lay too deep in the right atrium, thus causing the arrhythmia.After the shortening of the catheter the complaints of the patient were gone.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key5017508
MDR Text Key23537595
Report Number1063481-2015-00170
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K124039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Report Date 07/28/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1001
Device Lot NumberH14VC041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/28/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age51 YR
-
-